共 9 条
[2]
Ewer MS, 1999, SEMIN ONCOL, V26, P96
[3]
Feldman AM, 2000, CIRCULATION, V102, P272
[4]
KORTE MD, EUR J CANC
[7]
SUTER TM, 2007, IN PRESS J CLIN ONCO, V25
[8]
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (31)
:7811-7819